AstraZeneca EBITDA 2010-2024 | AZN

AstraZeneca EBITDA for the quarter ending June 30, 2024 was $4.025B, a 7.85% increase year-over-year.

  • AstraZeneca 2023 EBITDA was 13.58B, a 47.02% increase from 2022.
  • AstraZeneca 2022 EBITDA was 9.237B, a 21.76% increase from 2021.
  • AstraZeneca 2021 EBITDA was 7.586B, a 8.72% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

AstraZeneca EBITDA 2010-2024 | AZN

  • AstraZeneca 2023 EBITDA was 13.58B, a 47.02% increase from 2022.
  • AstraZeneca 2022 EBITDA was 9.237B, a 21.76% increase from 2021.
  • AstraZeneca 2021 EBITDA was 7.586B, a 8.72% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B